DE · DY2.DE
DENTSPLY SIRONA Inc.
- Sector
- Healthcare · Medical - Equipment & Services
- Headquarters
- Charlotte, NC
- Website
- dentsplysirona.com
Price · as of 2022-12-31
$17.77
Market cap 3.76B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2008 | $7.60 | $27.50 | |||
| 2009 | $8.30 | $10.40 | |||
| 2010 | $8.50 | $17.00 | |||
| 2011 | $2.70 | $32.10 | |||
| 2012 | $6.60 | $43.30 | |||
| 2013 | $7.80 | $16.70 | |||
| 2014 | $7.70 | $14.00 | |||
| 2015 | $6.10 | $0.10 | |||
| 2016 | $13.10 | $78.20 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $0.00 | $0.00 | |||
| 2019 | $6.90 | $9.10 | |||
| 2020 | $0.00 | $2.60 | |||
| 2021 | $7.00 | $56.20 | |||
| 2022 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates DENTSPLY SIRONA Inc.'s (DY2.DE) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $17.77
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
About DENTSPLY SIRONA Inc.
Dentsply Sirona, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 16,400 full-time employees. The firm develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. The company operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
- CEO
- Donald Casey
- Employees
- 15.2K
- Beta
- 0.00
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $17.77) − 1 = — (DCF, example).